株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中東の自動微生物検査市場:各種分子診断検査の販売量・販売額予測、サプライヤーシェア、競争戦略、検査装置、技術

2017 Middle East Automated Microbiology Market: Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

発行 Venture Planning Group 商品コード 448735
出版日 ページ情報 英文 500 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。

Local License: 同一事業所内

中東の自動微生物検査市場:各種分子診断検査の販売量・販売額予測、サプライヤーシェア、競争戦略、検査装置、技術 2017 Middle East Automated Microbiology Market: Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
出版日: ページ情報: 英文 500 Pages
概要

当レポートでは、中東諸国における自動微生物検査の市場について分析し、検査方法 (分子診断薬など) の概要や、現在/将来の技術水準、各国市場の動向見通し (今後5年間分:検査件数、売上高)、主要サプライヤーのプロファイル、今後の市場機会などを調査・推計しております。

目次・図表一覧

国別の市場動向

  • バーレーン
  • イラン
  • イラク
  • イスラエル
  • ヨルダン
  • クウェート
  • レバノン
  • オマーン
  • カタール
  • サウジアラビア
  • アラブ首長国連邦 (UAE)

各種疾患向け分子診断薬を開発・上市している主要企業

  • AIDS
  • アデノウイルス
  • バルトネラ菌
  • カンピロバクター
  • カンジダ
  • クラミジア
  • クロストリジウム
  • コロナウイルス
  • クリプトストリジウム
  • サイトメガロウイルス (CMV)
  • エコーウイルス
  • エンテロウイルス
  • エプスタイン・バーウイルス (EBV)
  • ジアルジア
  • 淋病
  • ハンタウイルス
  • ヘリコバクターピロリ
  • 肝炎
  • ヘルペス
  • インフルエンザ
  • レジオネラ菌
  • ライム病
  • リンパ肉芽腫
  • マラリア
  • 麻疹
  • 髄膜炎
  • ミクロスポリジウム
  • 単核症
  • おたふく風邪
  • マイコプラズマ
  • パピローマウイルス
  • パルボウイルス
  • 肺炎
  • 呼吸器合胞体ウイルス (RSV)
  • ロタウイルス
  • 風疹
  • サルモネラ菌
  • 敗血症
  • 細菌性赤痢
  • ブドウ球菌
  • 連鎖球菌
  • 梅毒
  • トキソプラズマ
  • トリコモナス
  • 結核
  • 西ナイルウイルス
  • エルシニア
目次
Product Code: VPAM23313

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 11-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Country Analyses

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

Specimen Types

- Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva

Applications

- Microbial Identification  Antibiotic Susceptibility  Urine Screening  Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Companies developing or marketing microbiology products, by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains over 500 pages and 54 tables

Table of Contents

List of Tables

  • Bahrain
  • Microbiology Specimen Volume Forecast by Type
  • Bahrain
  • Microbiology Test Volume Forecasts by Application
  • Bahrain
  • Microbiology Consumables Market Forecast by Application
  • Bahrain
  • Infectious Disease Test Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Diagnostics Market Forecast by Test
  • Bahrain
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Bahrain
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iran
  • Microbiology Specimen Volume Forecast by Type
  • Iran
  • Microbiology Test Volume Forecasts by Application
  • Iran
  • Microbiology Consumables Market Forecast by Application
  • Iran
  • Infectious Disease Test Volume Forecast by Assay
  • Iran
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iran
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iran
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Iraq
  • Microbiology Specimen Volume Forecast by Type
  • Iraq
  • Microbiology Test Volume Forecasts by Application
  • Iraq
  • Microbiology Consumables Market Forecast by Application
  • Iraq
  • Infectious Disease Test Volume Forecast by Assay
  • Iraq
  • Infectious Disease Diagnostics Market Forecast by Test
  • Iraq
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Iraq
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Israel
  • Microbiology Specimen Volume Forecast by Type
  • Israel
  • Microbiology Test Volume Forecasts by Application
  • Israel
  • Microbiology Consumables Market Forecast by Application
  • Israel
  • Infectious Disease Test Volume Forecast by Assay
  • Israel
  • Infectious Disease Diagnostics Market Forecast by Test
  • Israel
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Israel
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Jordan
  • Microbiology Specimen Volume Forecast by Type
  • Jordan
  • Microbiology Test Volume Forecasts by Application
  • Jordan
  • Microbiology Consumables Market Forecast by Application
  • Jordan
  • Infectious Disease Test Volume Forecast by Assay
  • Jordan
  • Infectious Disease Diagnostics Market Forecast by Test
  • Jordan
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Jordan
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Kuwait
  • Microbiology Specimen Volume Forecast by Type
  • Kuwait
  • Microbiology Test Volume Forecasts by Application
  • Kuwait
  • Microbiology Consumables Market Forecast by Application
  • Kuwait
  • Infectious Disease Test Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Diagnostics Market Forecast by Test
  • Kuwait
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Kuwait
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Lebanon
  • Microbiology Specimen Volume Forecast by Type
  • Lebanon
  • Microbiology Test Volume Forecasts by Application
  • Lebanon
  • Microbiology Consumables Market Forecast by Application
  • Lebanon
  • Infectious Disease Test Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Diagnostics Market Forecast by Test
  • Lebanon
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Lebanon
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Oman
  • Microbiology Specimen Volume Forecast by Type
  • Oman
  • Microbiology Test Volume Forecasts by Application
  • Oman
  • Microbiology Consumables Market Forecast by Application
  • Oman
  • Infectious Disease Test Volume Forecast by Assay
  • Oman
  • Infectious Disease Diagnostics Market Forecast by Test
  • Oman
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Oman
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Qatar
  • Microbiology Specimen Volume Forecast by Type
  • Qatar
  • Microbiology Test Volume Forecasts by Application
  • Qatar
  • Microbiology Consumables Market Forecast by Application
  • Qatar
  • Infectious Disease Test Volume Forecast by Assay
  • Qatar
  • Infectious Disease Diagnostics Market Forecast by Test
  • Qatar
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Qatar
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Saudi Arabia
  • Microbiology Specimen Volume Forecast by Type
  • Saudi Arabia
  • Microbiology Test Volume Forecasts by Application
  • Saudi Arabia
  • Microbiology Consumables Market Forecast by Application
  • Saudi Arabia
  • Infectious Disease Test Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Diagnostics Market Forecast by Test
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • Saudi Arabia
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • United Arab Emirates
  • Microbiology Specimen Volume Forecast by Type
  • United Arab Emirates
  • Microbiology Test Volume Forecasts by Application
  • United Arab Emirates
  • Microbiology Consumables Market Forecast by Application
  • United Arab Emirates
  • Infectious Disease Test Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Diagnostics Market Forecast by Test
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Volume Forecast by Assay
  • United Arab Emirates
  • Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests